The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.


Updates from The Motley Fool

Latest updates on Novogen from Fool.com.
7 Highly Rated Stocks on Sale

Check out these highly rated stocks that have had a big price cut in the past month.



Stock Performance

View Interactive NVGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novogen.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Novogen.
CAPS Rating 0 out of 5
 
54 Outperform
8 Underperform
CAPS All Stars
 
5 Outperform
2 Underperform

How do you think Novogen will perform against the market?



You pick for Novogen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Graham Kelly, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novogen.

The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers